跳至主要内容
临床试验/NCT00147030
NCT00147030已完成不适用

Whole Body Hypothermia for the Treatment of Perinatal Asphyxial Encephalopathy

Imperial College London1 个研究点 分布在 1 个国家目标入组 325 人开始时间: 2002年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
325
试验地点
1
主要终点
Combined Incidence of Mortality and Severe Neurodevelopmental Disability in Survivors

研究概览

简要总结

Hypothesis: Prolonged whole body cooling in term infants with perinatal asphyxial encephalopathy reduces death and severe neurodevelopmental disability.

This study aims to determine whether whole body cooling to 33-34°C is a safe treatment that improves survival, without severe neurological or neurodevelopmental impairments at 18 months, of term infants suffering perinatal asphyxial encephalopathy.

详细描述

This is a multicentre prospective randomised controlled trial to determine whether a reduction of body temperature by 3-4°C following perinatal asphyxia improves survival without neurodevelopmental disability.

Full term infants will be randomised within 6 hours of birth to either a control group with the rectal temperature kept at 37 ± 0.2°C or to whole body cooling with the rectal temperature kept at 33.5 ± 0.5°C for 72 hours followed by slow rewarming.

The outcome will be assessed at 18 months of age by survival and neurological and neurodevelopmental testing.

Eligibility criteria:

Term infants less than 6 hours after birth with moderate or severe perinatal asphyxia (a combination of clinical and EEG criteria).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Hour 至 6 Hours(Child)
性别
All
接受健康志愿者
否

入选标准

  • •The infant will be assessed sequentially by criteria A, B and C listed below:
  • •A. Infants =>36 completed weeks gestation admitted to the Neonatal Intensive Care Unit (NICU) with at least one of the following:
  • •Apgar score of =<5 at 10 minutes after birth
  • •Continued need for resuscitation, including endotracheal or mask ventilation, at 10 minutes after birth
  • •Acidosis within 60 minutes of birth (defined as any occurrence of umbilical cord, arterial or capillary pH <7.00)
  • •Base Deficit =>16 mmol/L in umbilical cord or any blood sample (arterial, venous or capillary) within 60 minutes of birth
  • •Infants that meet criteria A will be assessed for whether they meet the neurological abnormality entry criteria (B) by trained personnel:
  • •B. Moderate to severe encephalopathy, consisting of altered state of consciousness (lethargy, stupor or coma) AND at least one of the following:
  • •hypotonia
  • •abnormal reflexes including oculomotor or pupillary abnormalities
  • •absent or weak suck
  • •clinical seizures
  • •Infants that meet criteria A & B will be assessed by amplitude-integrated electroencephalogram (aEEG) (read by trained personnel):
  • •C. At least 30 minutes duration of amplitude integrated EEG recording that shows abnormal background aEEG activity or seizures. There must be one of the following:
  • •normal background with some seizure activity
  • •moderately abnormal activity
  • •suppressed activity
  • •continuous seizure activity

排除标准

  • •Infants expected to be > 6 hours of age at the time of randomisation
  • •Major congenital abnormalities, such as diaphragmatic hernia requiring ventilation, or congenital abnormalities suggestive of chromosomal anomaly or other syndromes that include brain dysgenesis

研究组 & 干预措施

cooled

Active Comparator

Whole body mild induced hypothermia for 72 hours, starting by 6 hours of age, in addition to standard intensive care. After 72 hours of cooling, rewarming by a maximum of 0.5 degree C / hour to normothermia.

干预措施: Whole body mild induced hypothermia (Procedure)

non-cooled

No Intervention

Standard intensive care

结局指标

主要结局

Combined Incidence of Mortality and Severe Neurodevelopmental Disability in Survivors

时间窗: 18 months

Severe neurodevelopmental disability was defined as a score of less than 70 on the Mental Developmental Index of the Bayley Scales of Infant Development II (BSID-II) (on which the standardization mean \[± standard deviation (SD)\] is 100±15 and higher scores indicate better performance), a score of 3 to 5 on the Gross Motor Function Classification System (GMFCS) (on which scores can range from 1 to 5, with higher scores indicating greater impairment), or bilateral cortical visual impairment with no useful vision.

次要结局

  • Culture Proven Sepsis(Duration of hospital stay, on average 22 days)
  • Major Venous Thrombosis(Duration of hospital stay, on average 22 days)
  • Sensorineural Hearing Loss(18 months)
  • Intracranial Haemorrhage(Duration of hospital stay, on average 22 days)
  • Persistent Hypotension(Duration of hospital stay, on average 22 days)
  • Pulmonary Hypertension(Duration of hospital stay, on average 22 days)
  • Prolonged Blood Coagulation Time(Duration of hospital stay, on average 22 days)
  • Necrotising Enterocolitis(Duration of hospital stay, on average 22 days)
  • Cardiac Arrhythmia(Duration of hospital stay, on average 22 days)
  • Thrombocytopenia(Duration of hospital stay, on average 22 days)
  • Pulmonary Haemorrhage(Duration of hospital stay, on average 22 days)
  • Epilepsy (Defined as Recurrent Seizures Beyond the Neonatal Period, Requiring Anticonvulsant Therapy at the Time of Assessment)(18 months)
  • Renal Failure Treated With Dialysis(Duration of hospital stay, on average 22 days)
  • Severe Neurodevelopmental Disability(18 months)
  • Microcephaly(18 months)
  • Pneumonia(Before discharge from hospital)
  • Pulmonary Airleak(Duration of hospital stay, on average 22 days)
  • Duration of Hospitalisation(Duration of hospital stay, on average 22 days)
  • Mortality(18 months)
  • Multiple Handicap(18 months)
  • Bayley Psychomotor Developmental Index Score (PDI)(18 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验